China Pharma Holdings, Inc. (CPHI)
USD 1.91
(-3.54%)
USD 1.91
(-3.54%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 3.21 Million USD | -52.28% |
| 2022 | 6.72 Million USD | -11.82% |
| 2021 | 7.62 Million USD | 17.91% |
| 2020 | 6.47 Million USD | 86.18% |
| 2019 | 3.47 Million USD | -47.59% |
| 2018 | 6.63 Million USD | -16.07% |
| 2017 | 7.9 Million USD | -7.09% |
| 2016 | 8.5 Million USD | -20.51% |
| 2015 | 10.69 Million USD | -15.25% |
| 2014 | 12.62 Million USD | 10.73% |
| 2013 | 11.4 Million USD | 1458.83% |
| 2012 | 731.36 Thousand USD | 714.03% |
| 2011 | -119.1 Thousand USD | -233.78% |
| 2010 | 89.03 Thousand USD | -47.0% |
| 2009 | 167.97 Thousand USD | 103.78% |
| 2008 | -4.44 Million USD | -615.23% |
| 2007 | 863.09 Thousand USD | -85.31% |
| 2006 | 5.87 Million USD | 1465.99% |
| 2005 | -430.25 Thousand USD | -512107.14% |
| 2004 | -84.00 USD | -100.01% |
| 2003 | 763.73 Thousand USD | 53.25% |
| 2002 | 498.36 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 648.84 Thousand USD | -79.79% |
| 2024 Q2 | 3.31 Million USD | 411.36% |
| 2023 Q3 | 4.02 Million USD | -41.58% |
| 2023 Q1 | 7.48 Million USD | 11.25% |
| 2023 Q2 | 6.88 Million USD | -7.97% |
| 2023 FY | 3.21 Million USD | -52.28% |
| 2023 Q4 | 3.21 Million USD | -20.22% |
| 2022 FY | 6.72 Million USD | -11.82% |
| 2022 Q4 | 6.72 Million USD | -16.2% |
| 2022 Q2 | 8.32 Million USD | 1.48% |
| 2022 Q1 | 8.2 Million USD | 7.51% |
| 2022 Q3 | 8.02 Million USD | -3.55% |
| 2021 Q1 | 6.68 Million USD | 3.28% |
| 2021 Q2 | 6.25 Million USD | -6.41% |
| 2021 Q3 | 7.07 Million USD | 13.18% |
| 2021 Q4 | 7.62 Million USD | 7.77% |
| 2021 FY | 7.62 Million USD | 17.91% |
| 2020 Q3 | 4.69 Million USD | 4.23% |
| 2020 FY | 6.47 Million USD | 86.18% |
| 2020 Q1 | 4.39 Million USD | 26.44% |
| 2020 Q2 | 4.5 Million USD | 2.55% |
| 2020 Q4 | 6.47 Million USD | 37.76% |
| 2019 Q4 | 3.47 Million USD | -15.83% |
| 2019 Q1 | 6.78 Million USD | 2.32% |
| 2019 FY | 3.47 Million USD | -47.59% |
| 2019 Q2 | 5.43 Million USD | -19.91% |
| 2019 Q3 | 4.12 Million USD | -24.02% |
| 2018 Q3 | 7.36 Million USD | -14.44% |
| 2018 Q2 | 8.6 Million USD | 6.08% |
| 2018 FY | 6.63 Million USD | -16.07% |
| 2018 Q1 | 8.11 Million USD | 2.66% |
| 2018 Q4 | 6.63 Million USD | -9.93% |
| 2017 Q2 | 11 Million USD | 19.5% |
| 2017 Q1 | 9.2 Million USD | 8.29% |
| 2017 FY | 7.9 Million USD | -7.09% |
| 2017 Q4 | 7.9 Million USD | -16.16% |
| 2017 Q3 | 9.42 Million USD | -14.37% |
| 2016 Q2 | 11.22 Million USD | 18.31% |
| 2016 Q1 | 9.48 Million USD | -11.32% |
| 2016 FY | 8.5 Million USD | -20.51% |
| 2016 Q4 | 8.5 Million USD | -19.5% |
| 2016 Q3 | 10.56 Million USD | -5.88% |
| 2015 FY | 10.69 Million USD | -15.25% |
| 2015 Q4 | 10.69 Million USD | -7.54% |
| 2015 Q3 | 11.57 Million USD | -14.4% |
| 2015 Q2 | 13.51 Million USD | 6.12% |
| 2015 Q1 | 12.73 Million USD | 0.9% |
| 2014 Q2 | 13.44 Million USD | 7.05% |
| 2014 Q4 | 12.62 Million USD | -7.23% |
| 2014 FY | 12.62 Million USD | 10.73% |
| 2014 Q1 | 12.55 Million USD | 10.17% |
| 2014 Q3 | 13.6 Million USD | 1.2% |
| 2013 Q1 | 36.81 Thousand USD | -94.97% |
| 2013 Q4 | 11.4 Million USD | 65.18% |
| 2013 FY | 11.4 Million USD | 1458.83% |
| 2013 Q3 | 6.9 Million USD | 195.56% |
| 2013 Q2 | 2.33 Million USD | 6242.7% |
| 2012 FY | 731.36 Thousand USD | 714.03% |
| 2012 Q1 | 271.55 Thousand USD | 327.99% |
| 2012 Q2 | -1.37 Million USD | -605.45% |
| 2012 Q3 | -1.47 Million USD | -7.15% |
| 2012 Q4 | 731.36 Thousand USD | 149.73% |
| 2011 Q4 | -119.1 Thousand USD | 88.89% |
| 2011 Q2 | -1.05 Million USD | -131.61% |
| 2011 Q3 | -1.07 Million USD | -1.4% |
| 2011 Q1 | -456.32 Thousand USD | -612.54% |
| 2011 FY | -119.1 Thousand USD | -233.78% |
| 2010 Q3 | -1.57 Million USD | -122.09% |
| 2010 Q2 | -709.41 Thousand USD | 27.7% |
| 2010 Q1 | -981.24 Thousand USD | -684.17% |
| 2010 FY | 89.03 Thousand USD | -47.0% |
| 2010 Q4 | 89.03 Thousand USD | 105.65% |
| 2009 FY | 167.97 Thousand USD | 103.78% |
| 2009 Q1 | -2.66 Million USD | 39.99% |
| 2009 Q2 | -1.15 Million USD | 56.56% |
| 2009 Q3 | -42.27 Thousand USD | 96.35% |
| 2009 Q4 | 167.97 Thousand USD | 497.35% |
| 2008 FY | -4.44 Million USD | -615.23% |
| 2008 Q2 | -4.56 Million USD | -362.42% |
| 2008 Q3 | -5.83 Million USD | -27.95% |
| 2008 Q4 | -4.44 Million USD | 23.84% |
| 2008 Q1 | 1.73 Million USD | 101.47% |
| 2007 Q4 | 863.09 Thousand USD | -83.01% |
| 2007 FY | 863.09 Thousand USD | -85.31% |
| 2007 Q3 | 5.07 Million USD | 19.14% |
| 2007 Q2 | 4.26 Million USD | 16.86% |
| 2007 Q1 | 3.64 Million USD | -37.94% |
| 2006 FY | 5.87 Million USD | 1465.99% |
| 2006 Q4 | 5.87 Million USD | -6.09% |
| 2006 Q3 | 6.25 Million USD | 54.11% |
| 2006 Q2 | 4.06 Million USD | -2.52% |
| 2006 Q1 | 4.16 Million USD | 0.0% |
| 2005 Q2 | - USD | 100.0% |
| 2005 Q3 | 2.74 Million USD | 0.0% |
| 2005 Q1 | -84.00 USD | 0.0% |
| 2005 FY | -430.25 Thousand USD | -512107.14% |
| 2004 Q4 | -84.00 USD | 0.0% |
| 2004 FY | -84.00 USD | -100.01% |
| 2004 Q1 | -84.00 USD | 6.67% |
| 2004 Q2 | 68.32 Thousand USD | 81435.71% |
| 2004 Q3 | -84.00 USD | -100.12% |
| 2003 Q1 | 795.97 Thousand USD | 8.21% |
| 2003 FY | 763.73 Thousand USD | 53.25% |
| 2003 Q2 | 763.73 Thousand USD | -4.05% |
| 2003 Q4 | -90.00 USD | 74.5% |
| 2003 Q3 | -353.00 USD | -100.05% |
| 2002 Q1 | 276.63 Thousand USD | 9.04% |
| 2002 Q2 | 498.36 Thousand USD | 80.15% |
| 2002 Q3 | 438.4 Thousand USD | -12.03% |
| 2002 Q4 | 735.6 Thousand USD | 67.79% |
| 2002 FY | 498.36 Thousand USD | 0.0% |
| 2001 Q4 | 253.68 Thousand USD | 21.1% |
| 2001 Q3 | 209.49 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| cbdMD, Inc. | 1.88 Million USD | -70.301% |
| cbdMD, Inc. | 1.88 Million USD | -70.301% |
| Zomedica Corp. | -10.22 Million USD | 131.405% |